Disclosure Of First-Time Adoption [Text Block]

PCI Biotech Holding - Filing #5867918

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
- NOK
1 119 NOK
22 333 NOK
23 453 NOK
39 043 NOK
- NOK
1 119 NOK
37 923 NOK
57 403 NOK
54 577 NOK
111 979 NOK
- NOK
Comprehensive income
- NOK
- NOK
16 417 NOK
16 417 NOK
20 315 NOK
- NOK
- NOK
20 315 NOK
Profit (loss)
- NOK
- NOK
16 417 NOK
16 417 NOK
20 315 NOK
- NOK
- NOK
20 315 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.